Innacell-gamma delta (Innate Pharma)

N/A

Report date: 2022/11/02 15:59:16

Base Information

Drug NameInnacell-gamma delta (Innate Pharma)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionImmunologic cytotoxicityLymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInnate Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesInnate Pharma

Active IndicationsN/A

Inactive IndicationsCarcinoma, Renal Cell

ATC CodeN/A